An animal model for continuous drug administration to the inner ear

Audiological Medicine

Volumn 2, Issue 3, 2004, Pages 174-178

  Cayé Thomasen, Per ^a   Wagner, Niels ^a   Engmer, Cecilia ^b   Laurell, Göran ^b   Bagger Sjoback, Dan ^b   Thomsen, Jens ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cochlear hair cell loss; Gentamicin; Inner ear morphology; Ototoxicity

Indexed keywords

GENTAMICIN;

ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; GUINEA PIG; HAIR CELL; INNER EAR; MALE; MORPHOLOGY; NONHUMAN; OSMOTIC MINIPUMP; OTOTOXICITY; PRIORITY JOURNAL;

EID: 5344266690     PISSN: 1651386X     EISSN: None     Source Type: Journal    
DOI: 10.1080/16513860410018006     Document Type: Conference Paper

References (5)

1. Blakley BW. Clinical forum: a review of intratympanic therapy. Am J Otol 1997, 18: 520-6.
2. Thomsen J, Charabi S, Tos M Preliminary results of a new delivery system for gentamicin to the inner ear in patients with Menières disease. Eur Arch Otorhinolaryngol 2000; 257: 362-5
3. Hoffer ME, Kopke RD, Weisskopf P, Gottshall K, Allen K, Wester D, Balaban C Use of the round window microcatheter in the treatment of Menières disease. Laryngoscope 2001, 111 2046-9.
4. Johnson A-C, Canlon B. Progressive hair cell loss induced by toluene exposure. Hear Res 1994; 75: 201-8
5. Hoffer ME, Allen K, Kopke RD, Weisskopf P, Gottshall K, Wester D Transtympanic versus sustained release administration of gentamicin: kinetics, morphology, and function. Laryngoscope 2001, 111: 1343-57.